http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Modulith SLX 체외충격파 쇄석기를 이용한 요석 치험 707례
임희관 圓光大學校 醫科學硏究所 1997 圓光醫科學 Vol.13 No.1-2
Purpose: We attempted to assess the results of Modulith SLX lithotripsy for management of urinary stones. Materials and methods: Between January 3, 1995 and December 31, 1996, 707 renal units in 668 patients with urinary stones were treated by extracorporeal shock wave lithotripsy (ESWL) with the Modulith SLX lithotriptor. Results: 1. The average age of patients was 49.6 years, with a range of 5 to 93 years. There were 395 male patients and 273 female patients with a ratio of sex 1.45 : 1. 2. The stones were located in the kidney (except staghorn calculi) in 160 cases (22.6%), staghorn calculi in 13 cases (1.8%), ureteropelvic junction (UPJ) in 19 cases (2.7%), upper ureter in 200 cases (28.3%), mid ureter in 34 cases (4.9%), lower ureter in 271 cases (38.3%) and bladder in 10 cases (1.4%). 3. Average treatment sessions and time (min.) were 1.8 ± 1.4 and 28.6 ± 4.2, respectively. 4. Success rates according to stone size were 99.6% in less than 1㎠, 97.2% in 1㎠ to 2㎠, 91.3% in 2㎠ to 3㎠ and 78.1% more than 3㎠. 5. Success rates according to stone location were 100% in renal stones (except staghorn calculi), 84.6% in staghorn calculi, 94.7% in UPJ stones, 98.5% in upper ureteral stones, and 98.6% in lower ureteral stones and 30% in bladder stones. 6. Complications were gross hematuria (≥3days) in 76 cases(10.7%), steinstrasse in 89 cases(12.5%), fever (≥38℃) in 16 cases(2.3%) and perirenal hematoma in 5 cases(0.7%). Conclusions: We conclude that extracorporeal shock wave lithotripsy with Modulith SLX lithotriptor is a safe and effective procedure for the treatment of urinary stones.
EDAP LT-01+ 체외충격파쇄석기를 이용한 요로결석 치험 1,237례
임희관,김봉주,임정식 圓光大學校 醫科學硏究所 1993 圓光醫科學 Vol.9 No.1-2
Between February 8, 1990 and February 28, 1993, 1,237 renal units in 1,081 patients with urinary stones were treated by extracorporeal shock wave lithotripsy(ESWL) with the EDAP LT-01+lithotriptor. The results were obtained as follows ; 1. The average patient age was 44.3 years, with a range of 16 months to 92 years. The sex ratio was about 1.46 : 1,641(59.3%) male and 440(40.7%) female patients. 2. The locations of stones were kidney in 564 cases(45.6%) including 35 cases of staghorn calculi, ureter in 665 cases(53.8%) and bladder in 8 cases(0.6%). 3. The average number of treatments was 3.5 sessions and average treatment time was 36.5 minutes. 4. Of the 1,237 cases, 105 cases(8.5%) complained of severe pain and requires intravenous or intramuscular analgesics. 5. The success rate of treatment-ended patients(including particles less than 4㎜ in size) was 95.0%. 6. Additional measures used were : push up procedures in 30 cases and double-J stenting in 54 cases. 7. The post-ESWL complications were persistent gross hematuria lasting more than three days in 22 cases, high fever(>38℃) in 26 cases and steinstrasse in 51 cases. We conclude that extracorporeal shock wave lithotripsy with EDAP LT-01+lithotriptor is a safe and effective procedure for the treatment of urinary stones.
전립선비대증에서 경요도전립선절제술, 경요도전립선전기기화술, 경요도극초단파고온열치료, 약물요법의 치료결과
오상진,임희관,임정식 圓光大學校 醫科學硏究所 1999 圓光醫科學 Vol.15 No.1
Background: The therapeutic modalities in the management of benign prostatic hyperplasia have changed dramatically over the past 10 years. We, therefore, investigated therapeutic results of several types of treatment options. Materials and Methods: From February 1993 to August 1997. the results of transurethral resection of prostate(TURP: 57 patients), transurethral electrovaporization of prostate(TUEP: 21 patients), transurethral microwave thermotherapy{TUMT: 28 patients) and medication(52 patients) were analyzed. Efficacy parameters evaluated included symptom score, urinary flow rate, postvoid residual urine and complications. Results: The symptomatic improvement was 82.5% in the TURP group, 80% in the TUEP group, 65.0% in the TUMT group and 71.4% in the medication group. There were statistically significant improvements in symptom score for TURP, TUEP and medication groups. The improvement in the maximal flow rate was 84.2% in the TURP group, 66.7% in the TUEP group, 50% in the TUMT group and 41.7% in the medication group. There were statistically significant improvements in flow rate for TURP and TUEP groups. The improvement in postvoid residual urine was 88.2% in the TURP group, 64.3% in the TUEP group, 53.9% in the TUMT group and 56.0% in the medication group. There were statistically significant improvements in postvoid residual urine for TURP and TUEP groups. The incidence of complications were 8 in 57(14%) in the TURP group and 2 in 21(9.5%) in the TUEP group. In TUMT group, no noticeable complications were observed. The adverse reactions were mild and transient in the medication group. Conclusions: The results of TURP and TUEP compared to those of TUMT and medication group were exellent. With these results, we can conclude that TURP is the most effective treatment method of the four treatment options for symptomatic BPH. TUEP is recommended as an alternative for patients with a small prostate. Medication delivers symptomatic improvements with mild adverse reactions. One session of TUMT seems to have insignificant therapeutic effect on BPH patients.